BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 2482733)

  • 21. Reaction of alpha 2-macroglobulin with plasmin increases binding of transforming growth factors-beta 1 and beta 2.
    LaMarre J; Wollenberg GK; Gonias SL; Hayes MA
    Biochim Biophys Acta; 1991 Jan; 1091(2):197-204. PubMed ID: 1704799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
    Takada Y; Takada A
    Thromb Res; 1989 Apr; 54(2):133-9. PubMed ID: 2526391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the reaction of plasmin with alpha 2-macroglobulin: effect of antifibrinolytic agents.
    Steiner JP; Migliorini M; Strickland DK
    Biochemistry; 1987 Dec; 26(25):8487-95. PubMed ID: 2450563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of tumor necrosis factor alpha to activated forms of human plasma alpha 2 macroglobulin.
    Wollenberg GK; LaMarre J; Rosendal S; Gonias SL; Hayes MA
    Am J Pathol; 1991 Feb; 138(2):265-72. PubMed ID: 1704186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
    Hermel M; Dailey W; Hartzer MK
    Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of immobilized human plasminogen and plasmin with streptokinase.
    Shi GY; Chang BI; Wu DH; Wu HL
    Biochem Biophys Res Commun; 1993 Aug; 195(1):192-200. PubMed ID: 8363600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural domains of streptokinase involved in the interaction with plasminogen.
    Rodríguez P; Fuentes P; Barro M; Alvarez JG; Muñoz E; Collen D; Lijnen HR
    Eur J Biochem; 1995 Apr; 229(1):83-90. PubMed ID: 7744053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.
    Webb DJ; Crookston KP; Figler NL; Lamarre J; Gonias SL
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):579-86. PubMed ID: 8526873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of thiolester bond cleavage-dependent conformational changes in binary alpha 2-macroglobulin-proteinase complexes.
    Roche PA; Pizzo SV
    Arch Biochem Biophys; 1988 Nov; 267(1):285-93. PubMed ID: 2461679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of insulin incorporation into alpha 2-macroglobulin: implications for the study of peptide and growth factor binding.
    Chu CT; Rubenstein DS; Enghild JJ; Pizzo SV
    Biochemistry; 1991 Feb; 30(6):1551-60. PubMed ID: 1704257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of a bacterial plasminogen activator intermediate between streptokinase and staphylokinase.
    Sazonova IY; Houng AK; Chowdhry SA; Robinson BR; Hedstrom L; Reed GL
    J Biol Chem; 2001 Apr; 276(16):12609-13. PubMed ID: 11278483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of human alpha 2-macroglobulin conformational variants by non-ideal high performance size-exclusion chromatography.
    Gonias SL; Roche PA; Pizzo SV
    Biochem J; 1986 Apr; 235(2):559-67. PubMed ID: 2427074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding and endocytosis of alpha 2-macroglobulin-plasmin complexes.
    Ney KA; Gidwitz S; Pizzo SV
    Biochemistry; 1985 Aug; 24(17):4586-92. PubMed ID: 2415157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The trypsin-inhibitory efficiency of human alpha 2-macroglobulin in the presence of alpha 1-proteinase inhibitor: evidence for the formation of an alpha 2-macroglobulin--alpha 1-proteinase inhibitor complex.
    Dejgaard S; Ortapamuk O; Ozer I
    J Enzyme Inhib; 1999; 14(5):391-405. PubMed ID: 10488249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactions.
    Gladysheva IP; Sazonova IY; Chowdhry SA; Liu L; Turner RB; Reed GL
    J Biol Chem; 2002 Jul; 277(30):26846-51. PubMed ID: 12016220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the binding of chicken alpha-macroglobulin and ovomacroglobulin to the mammalian alpha 2-macroglobulin receptor.
    Feldman SR; Pizzo SV
    Arch Biochem Biophys; 1984 Nov; 235(1):267-75. PubMed ID: 6208849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptokinase-dependent delayed activation of horse plasminogen.
    Marcum JA; Highsmith RF; Kline DL
    Biochim Biophys Acta; 1982 Dec; 709(1):19-27. PubMed ID: 6217838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase.
    Boxrud PD; Verhamme IM; Bock PE
    J Biol Chem; 2004 Aug; 279(35):36633-41. PubMed ID: 15215240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of human alpha 2-macroglobulin monomers obtained by reduction with dithiothreitol.
    Moncino MD; Roche PA; Pizzo SV
    Biochemistry; 1991 Feb; 30(6):1545-51. PubMed ID: 1704256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
    Collen D
    Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.